ITFI920078A1 - Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano - Google Patents

Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano

Info

Publication number
ITFI920078A1
ITFI920078A1 IT000078A ITFI920078A ITFI920078A1 IT FI920078 A1 ITFI920078 A1 IT FI920078A1 IT 000078 A IT000078 A IT 000078A IT FI920078 A ITFI920078 A IT FI920078A IT FI920078 A1 ITFI920078 A1 IT FI920078A1
Authority
IT
Italy
Prior art keywords
factor
human plasma
protrombinic
insulation
complex
Prior art date
Application number
IT000078A
Other languages
English (en)
Inventor
Silvana Arrighi
Maria Giuseppina Borri
Enzo Bucci
Francesco Norelli
Original Assignee
Aima Derivati Spa
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aima Derivati Spa, Sclavo Spa filed Critical Aima Derivati Spa
Priority to ITFI920078A priority Critical patent/IT1262899B/it
Publication of ITFI920078A0 publication Critical patent/ITFI920078A0/it
Priority to DE69326227T priority patent/DE69326227T2/de
Priority to EP93104633A priority patent/EP0617049B1/en
Priority to ES93104633T priority patent/ES2138603T3/es
Priority to AT93104633T priority patent/ATE184018T1/de
Priority to US08/038,942 priority patent/US5378365A/en
Publication of ITFI920078A1 publication Critical patent/ITFI920078A1/it
Application granted granted Critical
Publication of IT1262899B publication Critical patent/IT1262899B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
ITFI920078A 1992-03-22 1992-03-27 Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano IT1262899B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI920078A IT1262899B (it) 1992-03-27 1992-03-27 Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE69326227T DE69326227T2 (de) 1992-03-27 1993-03-22 Verfahren zur Isolation von hoch angereicherten Faktoren IX, X und II vom Prothrombin komplex oder menschlichem Plasma
EP93104633A EP0617049B1 (en) 1992-03-22 1993-03-22 Process for the isolation of highly purified factors IX, X and II from prothrombin complex or human plasma
ES93104633T ES2138603T3 (es) 1992-03-27 1993-03-22 Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
AT93104633T ATE184018T1 (de) 1992-03-27 1993-03-22 Verfahren zur isolation von hoch angereicherten faktoren ix, x und ii vom prothrombin komplex oder menschlichem plasma
US08/038,942 US5378365A (en) 1992-03-27 1993-03-26 Process for the isolation of highly purified factors IX, X and II from prothrombin complex or human plasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920078A IT1262899B (it) 1992-03-27 1992-03-27 Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano

Publications (3)

Publication Number Publication Date
ITFI920078A0 ITFI920078A0 (it) 1992-03-27
ITFI920078A1 true ITFI920078A1 (it) 1993-09-27
IT1262899B IT1262899B (it) 1996-07-22

Family

ID=11350034

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920078A IT1262899B (it) 1992-03-22 1992-03-27 Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano

Country Status (6)

Country Link
US (1) US5378365A (it)
EP (1) EP0617049B1 (it)
AT (1) ATE184018T1 (it)
DE (1) DE69326227T2 (it)
ES (1) ES2138603T3 (it)
IT (1) IT1262899B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
DE19504852C2 (de) * 1995-02-15 2003-01-23 Octapharma Ag Lachen Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
DE19625642A1 (de) * 1996-06-26 1998-01-08 Max Planck Gesellschaft Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren
AT409334B (de) * 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
SE0203551D0 (sv) * 2002-12-02 2002-12-02 Biovitrum Ab Prothrombin purification
GB0614315D0 (en) * 2006-07-19 2006-08-30 Ge Healthcare Bio Sciences Ab Chromatography columns, systems and methods
GB0704603D0 (en) * 2007-03-09 2007-04-18 Ge Healthcare Bio Sciences Ab Packing system and method for chromatography columns
US9597610B2 (en) * 2007-03-09 2017-03-21 Ge Healthcare Bioprocess R&D Ab Packing system and method for chromatography columns
US9597611B2 (en) * 2007-03-09 2017-03-21 Ge Healthcare Bioprocess R&D Ab Packing system and method for chromatography columns
GB0710321D0 (en) 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
US7934704B2 (en) * 2007-10-16 2011-05-03 Environmental Dynamics, Inc. Retrievable diffuser module with internal ballast/buoyancy chamber
ES2576109T3 (es) * 2008-12-02 2016-07-05 Novo Nordisk Health Care Ag Purificación de polipéptidos
KR20120118028A (ko) 2010-01-18 2012-10-25 노보 노르디스크 헬스 케어 악티엔게젤샤프트 혈액 응고 인자의 정제
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
ES2784628T3 (es) 2011-03-29 2020-09-29 Glaxosmithkline Llc Sistema de tampón para purificación de proteína
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
US4720385A (en) * 1983-03-29 1988-01-19 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DE3914869C1 (it) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5286849A (en) * 1992-07-14 1994-02-15 Alpha Therapeutic Corporation Purification of factor IX

Also Published As

Publication number Publication date
DE69326227T2 (de) 2000-02-17
EP0617049B1 (en) 1999-09-01
ES2138603T3 (es) 2000-01-16
EP0617049A1 (en) 1994-09-28
ATE184018T1 (de) 1999-09-15
DE69326227D1 (de) 1999-10-07
US5378365A (en) 1995-01-03
ITFI920078A0 (it) 1992-03-27
IT1262899B (it) 1996-07-22

Similar Documents

Publication Publication Date Title
ITFI920078A1 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DK142194A (da) Fremgangsmåde til affinitetsseparering
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
AU1702192A (en) Process for the purification of the inert gases
DE69435170D1 (de) Extrakorporeale Vorrichtungen zur Adsorption durch Affinität
HK1013806A1 (en) Antibody purification
BR8605129A (pt) Processo para purificacao de uma proteina atraves de cromatografia de coluna e processo para purificar fator anti-hemofilico a partir de crioprecipitado de plasma
KR960706283A (ko) 플라즈마 토치 (Plasma torch)
DE69410140D1 (de) Gasreinigungsverfahren
EP0391526A3 (en) Antibody purification process
NZ333900A (en) Purification of immunoglobulins from plasma and plasma fractions using macro-porous anion exchange resin
DE69316954D1 (de) Reinigung von Sauerstoff durch Adsorption
UA32529C2 (uk) Спосіб очистки стічних вод та пристрій для його здійснення
IL105142A0 (en) Method of improving the selectivity of carbon membranes by chemical carbon vapor deposition
GB2297279B (en) Process for the purification of a gas by scrubbing-venturi column for carrying out said process
HUT64777A (en) Method for producing virus-safe vii factor of high purity
AU7425194A (en) Purification of fluids by adsorption
CA2141439A1 (en) Method for highly purifying human serum albumin
EP0720618A4 (en) METHOD FOR CLEANING "BASIC" FIBROBLAST GROWTH FACTOR
ES2125938T3 (es) Procedimiento para la reactivacion de proteinas membranales purificadas.
ITMI910526A1 (it) Processo per la purificazione di gas fluorurati
GB9015323D0 (en) Process for the fine purification of gases
GB2267703B (en) Sorbent for treatment of effluent gas stream
DE69509741T2 (de) Verfahren zur Reinigung von Acetonitril durch Adsorptionsverfahren
IT1266654B1 (it) Procedimento per la purificazione della 9-(2-idrossi) etossimetilguanina

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970427